Shutterstock, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Shutterstock, Inc. on October 20, 2025. The filing addresses a significant regulatory development regarding the Company's previously announced merger with Getty Images Holdings, Inc.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on a material event regarding the proposed merger.
Material Changes and Events
- Regulatory Action: The UK's Competition and Markets Authority (CMA) intends to refer the proposed merger between Shutterstock and Getty Images to a Phase 2 review process.
- Condition for Avoidance: The Phase 2 referral will occur unless acceptable undertakings are offered to address the CMA's competition concerns.
- Company Stance: Shutterstock remains committed to the proposed merger and plans to continue engaging with the CMA and Getty Images to secure necessary clearances expeditiously.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the transaction's completion and regulatory approvals. Management emphasizes that actual results may differ materially from expectations due to risks and uncertainties. Key risks include the potential for the transaction to be delayed or not completed if regulatory approvals are not obtained on a timely basis or at all. Investors are directed to the "Risk Factors" section in the Company's and Getty Images' Annual Reports on Form 10-K and the definitive proxy statement/prospectus filed on April 30, 2025, for a comprehensive discussion of these risks.
Investor Verification Checklist
- Verify the specific competition concerns raised by the UK CMA in their public statements.
- Review the definitive proxy statement/prospectus filed on April 30, 2025, for detailed transaction terms and risk factors.
- Monitor for any subsequent filings regarding undertakings offered by the companies to the CMA.
- Check for updates on the timeline for the Phase 2 review process if the referral proceeds.